Aethlon Medical: all pre-funded warrants exercised; 1,604,095 shares outstanding

AETHLON MEDICAL INC

As of Aug 28, 2026, Aethlon Medical has 1,604,095 common shares outstanding.
All previously outstanding pre-funded warrants have been exercised.
CEO and CFO James B. Frakes signed the 8-K on Aug 31, 2026.

item 8.01

AETHLON MEDICAL INC filing history →

Source: SEC EDGAR

accession 0001683168-26-006815

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.